This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jan;120(1):219-20.

doi: 10.1016/j.ophtha.2012.07.022.

Bevacizumab, vitrectomy, and vitreous hemorrhage

Hamid Ahmadieh, Nasser Shoeibi

PMID: 23283198
DOI: 10.1016/j.ophtha.2012.07.022

Comment

Bevacizumab, vitrectomy, and vitreous hemorrhage

Hamid Ahmadieh et al. Ophthalmology. 2013 Jan.

. 2013 Jan;120(1):219-20.

doi: 10.1016/j.ophtha.2012.07.022.

Authors

Hamid Ahmadieh, Nasser Shoeibi

PMID: 23283198
DOI: 10.1016/j.ophtha.2012.07.022

No abstract available

PubMed Disclaimer

Comment in

Bevacizumab, vitrectomy, and vitreous hemorrhage. Author reply.
Ahn J, Woo SJ, Park KH. Ahn J, et al. Ophthalmology. 2013 Jan;120(1):220-1. doi: 10.1016/j.ophtha.2012.07.023. Ophthalmology. 2013. PMID: 23283199 No abstract available.

Comment on

The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
Ahn J, Woo SJ, Chung H, Park KH. Ahn J, et al. Ophthalmology. 2011 Nov;118(11):2218-26. doi: 10.1016/j.ophtha.2011.03.036. Epub 2011 Jul 2. Ophthalmology. 2011. PMID: 21724263 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information